Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)-Reference-Cited by-同舟云学术

Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)

Published:2014-06 Issue: Volume:81 Page:89-94
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Guo Xiaoke,Ma Xianglei,Yang Qian,Xu Jing,Huang Lu,Jia Jianmin,Shan Jiaojiao,Liu Li,Chen Weilin,Chu Hongxi,Wei Jinlian,Zhang Xiaojin,Sun Haopeng,Tang Yiqun,You Qidong

Funder

National Major Science and Technology Project of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference31 articles.

1. Novel molecular targets for atrial fibrillation therapy;Dobrev;Nature Reviews Drug Discovery,2012

2. Cognitive impairment associated with atrial fibrillation: a meta-analysis;Kalantarian;Annals of Internal Medicine,2013

3. Management of atrial fibrillation;Lip;Lancet,2007

4. Predicting the future in patients with atrial fibrillation: who develops heart failure?;Mulder;European Journal of Heart Failure,2013

5. Innovative approaches to anti-arrhythmic drug therapy;Nattel;Nature Reviews Drug Discovery,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition;Archiv der Pharmazie;2023-09-13

2. Сardioprotective agents with biaromatic structure. Part 5. Potassium Kv1.5-channels blockers;Pharmacokinetics and Pharmacodynamics;2023-07-18

3. miR-135a Regulates Atrial Fibrillation by Targeting Smad3;Cardiovascular Therapeutics;2023-05-05

4. Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors;Bioorganic & Medicinal Chemistry;2023-01

5. Rational Design and Synthesis of 3-Morpholine Linked Aromatic-Imino-1H-Indoles as Novel Kv1.5 Channel Inhibitors Sharing Vasodilation Effects;Frontiers in Molecular Biosciences;2022-01-24